[go: up one dir, main page]

Latest News for: bio

Edit

Bio-Works Technologies: Bio-Works Receives Order for 8,9 MSEK from Returning Customer (Bio-Works Technologies AB)

Public Technologies 06 Jul 2026
2026-07-06 08.00.00 Bio-Works Technologies AB. Bio-Works Receives Order for 8,9 MSEK from Returning Customer. Bio-Works Technologies AB has received a new order from a returning customer with an order value of 8,9 MSEK ... About Bio-Works.
Edit

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

The Milton Standard Journal 06 Jul 2026
PARIS & LONDON--(BUSINESS WIRE)--Jul 6, 2026-- ....
Edit

Novartis to Buy Myricx Bio for Up to $1.5 Billion

Wall Street Journal 06 Jul 2026
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities ... .
Edit

Erling Haaland: The Bio-Engineered Striker Rewriting Rules Of Modern Football

NDTV 06 Jul 2026
Erling Haaland combines a 6000-calorie ancestral diet, a disciplined sleep routine, and advanced recovery methods to optimize his football performance ... .
Edit

Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with ...

Killeen Daily Herald 06 Jul 2026
Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of ....
Edit

Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

The Daily Record - Dunn 06 Jul 2026
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ. BLTE) (“Belite Bio®” or the “Company”), a ....
Edit

Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of ...

The Facts 06 Jul 2026
("Matica Bio"), a viral vector contract development and ...
Edit

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

Caledonian Record 06 Jul 2026
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, ...
Edit

Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New ...

The Daily Record - Dunn 06 Jul 2026
MELBOURNE, Australia, July 06, 2026 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life sciences venture ....
Edit

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium (Belite Bio Inc)

Public Technologies 06 Jul 2026
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ ... Webcast Link InstructionsA webcast of the presentation can be accessed under "Events" in the investor relations section of the Belite Bio website at ... About Belite Bio.
Edit

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi ...

Nasdaq Globe Newswire 06 Jul 2026
Basel, July 6, 2026 - Novartis today announced that it ...
Edit

Novartis acquires British start-up Myricx Bio

Swissinfo 06 Jul 2026
Swiss pharmaceutical giant Novartis has agreed to pay an initial sum of $1.1 billion (CHF883 million) to acquire the British start-up Myricx Bio, which is developing antibody-drug conjugates for ...
Edit

Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"

PR Newswire 06 Jul 2026
SEOUL, South Korea, July 6, 2026 /PRNewswire/ -- Dx&Vx has successfully expanded its global partnering initiatives at the BIO International Convention 2026 (BIO USA), raising the visibility of its overseas out-licensing opportunities.
Edit

Novartis to buy UK biotech Myricx Bio for up to $1.5B

Anadolu Agency 06 Jul 2026
Swiss pharmaceutical company Novartis said Monday it has agreed to acquire UK-based biotechnology firm Myricx Bio for up to $1.5 billion to expand its oncology pipeline.
Edit

Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models

PR Newswire 06 Jul 2026
("Matica Bio"), a viral vector contract development and manufacturing organization (CDMO), is partnering with Texas-based biotech VaxDome Inc ... Matica Bio will execute the work at its purpose-built facility in College Station, Texas.

Article Search

tools
×
×
×
×